Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Viatris And Biocon Launch Bevacizumab Biosimilar In Canada
Abevmy Version Of Avastin Faces Multiple Other Biosimilar Rivals In The Market
May 19 2022
•
By
David Wallace
Abevmy is the fifth Avastin biosimilar approved in Canada • Source: Shutterstock
More from Biosimilars
More from Products